ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Tooru reports £1.06 million EBITDA in H1 2026

Health food group posts £5.2 million revenue and £1.06 million EBITDA for the six months to June 30, 2026, with Juvela and Pulsin brands driving growth.

PA
Priya Anand · Equities & Earnings Desk · 3 Sept 2026 · 23:55 · 1 min read
Share
Tooru reports £1.06 million EBITDA in H1 2026

Tooru plc reported an EBITDA of £1.06 million from its operating businesses for the six months ended June 30, 2026, alongside a net revenue increase to £5.2 million. The group’s cash position rose to £1.4 million as of June 30, up from £708,000 at the end of 2025.

The company’s Juvela brand generated £809,000 in EBITDA on net sales of £3.5 million, while Pulsin reported £154,000 in EBITDA on sales of £747,000. Pulsin cited cost savings from outsourced production and a new Swiss distribution agreement as key contributors to its performance. The OAF brand secured expanded listings with Tesco and new placements in Asda beginning April 2026, achieving year-on-year growth exceeding 100% in the first half of 2026.

Tooru’s net loss from continuing operations totaled £430,000 for the period, reflecting investment in growth initiatives. Total assets stood at £10.1 million as of June 30, down from £9.8 million at year-end 2025, while total liabilities reached £9.7 million. Gross cash proceeds of £980,000 were raised during the six months, and £300,000 of debt was converted.

Market Rocket, which contributed £99,000 in EBITDA on sales of £917,000 during the period, was sold after the reporting date. The company’s performance for the six months to June 30, 2025, included only a one-month contribution from acquired subsidiaries, limiting direct comparability with the latest results.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
ADVERTISEMENT